Compounds > plerixafor
Page last updated: 2024-08-24

plerixafor and Experimental Neoplasms

plerixafor has been researched along with Experimental Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Bai, R; Liang, Z; Shim, H; Wu, R; Xie, Y; Yao, C; Yoon, Y; Yu, W1
Jiang, TH; Mao, AW; Peng, J; Sun, XJ1
Han, AR; Kim, HJ; Kim, SH; Lee, JY; Min, WS; Park, G1
Huang, SM; Jeon, SB; Kim, JM; Kim, SJ; Koh, SS; Lee, Y; Lim, DS; Park, EH; Park, HD1
Chen, X; Farber, JM; Jacobson, O; Jacobus, JP; Kiesewetter, DO; Szajek, LP; Weiss, ID1
Chudakov, DM; Lewin, SA; Luker, GD; Luker, KE; Mihalko, LA; Ray, P; Schmidt, BT; Shcherbo, D1
Apicelli, A; Eagleton, MC; Hirbe, AC; Morgan, EA; Piwnica-Worms, D; Prior, JL; Trinkaus, K; Uluçkan, O; Weilbaecher, K1

Other Studies

7 other study(ies) available for plerixafor and Experimental Neoplasms

ArticleYear
Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.
    European journal of medicinal chemistry, 2020, Jan-01, Volume: 185

    Topics: Amides; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Proliferation; Chemokine CXCL12; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Injections, Intravenous; Lung Neoplasms; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Receptors, CXCR4; Structure-Activity Relationship; Tumor Cells, Cultured; Wound Healing

2020
Application of chemokine receptor antagonist with stents reduces local inflammation and suppresses cancer growth.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:11

    Topics: Animals; Benzylamines; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; Humans; Inflammation; Mice; Neoplasms, Experimental; Pancreatic Neoplasms; Receptors, CXCR4; Signal Transduction; Stents; Xenograft Model Antitumor Assays

2015
A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
    Oncology reports, 2015, Volume: 34, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Benzylamines; Bone Marrow Cells; Cell Movement; Chemokine CXCL12; Cyclams; Cytarabine; Female; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Male; Mice; Middle Aged; Neoplasms, Experimental; Neoplastic Stem Cells; Receptors, CXCR4; Tumor Microenvironment

2015
PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.
    Oncogene, 2010, Jan-07, Volume: 29, Issue:1

    Topics: Animals; Benzylamines; Blotting, Western; Cell Line, Tumor; Cell Movement; Cyclams; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Lectins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms, Experimental; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transplantation, Heterologous; Up-Regulation

2010
Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.
    Molecular imaging and biology, 2012, Volume: 14, Issue:1

    Topics: Animals; Benzylamines; Carcinoma, Lewis Lung; Cell Line, Tumor; CHO Cells; Copper Radioisotopes; Cricetinae; Cricetulus; Cyclams; Female; Heterocyclic Compounds; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Molecular Imaging; Neoplasms, Experimental; Ovarian Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Receptors, CXCR4; Tissue Distribution; Transfection; Transplantation, Heterologous

2012
In vivo imaging of ligand receptor binding with Gaussia luciferase complementation.
    Nature medicine, 2011, Dec-04, Volume: 18, Issue:1

    Topics: Animals; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; HEK293 Cells; Heterocyclic Compounds; Humans; Ligands; Luciferases; Luminescent Measurements; Mice; Molecular Imaging; Neoplasms, Experimental; Protein Binding; Receptors, CXCR; Receptors, CXCR4

2011
Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner.
    Blood, 2007, Apr-15, Volume: 109, Issue:8

    Topics: Animals; Anti-HIV Agents; Benzylamines; Bone Density; Bone Neoplasms; Bone Resorption; Cell Movement; Cyclams; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neutropenia; Neutrophils; Osteoclasts; Receptors, CXCR4; Tumor Burden

2007